An important challenge in segmenting real-world biomedical imaging data is the presence of multiple disease processes within individual subjects. Most adults above age 60 exhibit a variable degree of small vessel ischemic disease, as well as chronic infarcts, which will manifest as white matter hyperintensities (WMH) on brain MRIs. Subjects diagnosed with gliomas will also typically exhibit some degree of abnormal T2 signal due to WMH, rather than just due to tumor. We sought to develop a fully automated algorithm to distinguish and quantify these distinct disease processes within individual subjects’ brain MRIs. To address this multi-disease problem, we trained a 3D U-Net to distinguish between abnormal signal arising from tumors vs. WMH in the 3D multi-parametric MRI (mpMRI, i.e., native T1-weighted, T1-post-contrast, T2, T2-FLAIR) scans of the International Brain Tumor Segmentation (BraTS) 2018 dataset (ntraining = 285, nvalidation = 66). Our trained neuroradiologist manually annotated WMH on the BraTS training subjects, finding that 69% of subjects had WMH. Our 3D U-Net model had a 4-channel 3D input patch (80 × 80 × 80) from mpMRI, four encoding and decoding layers, and an output of either four [background, active tumor (AT), necrotic core (NCR), peritumoral edematous/infiltrated tissue (ED)] or five classes (adding WMH as the fifth class). For both the four- and five-class output models, the median Dice for whole tumor (WT) extent (i.e., union of AT, ED, NCR) was 0.92 in both training and validation sets. Notably, the five-class model achieved significantly (p = 0.002) lower/better Hausdorff distances for WT extent in the training subjects. There was strong positive correlation between manually segmented and predicted volumes for WT (r = 0.96) and WMH (r = 0.89). Larger lesion volumes were positively correlated with higher/better Dice scores for WT (r = 0.33), WMH (r = 0.34), and across all lesions (r = 0.89) on a log(10) transformed scale. While the median Dice for WMH was 0.42 across training subjects with WMH, the median Dice was 0.62 for those with at least 5 cm3 of WMH. We anticipate the development of computational algorithms that are able to model multiple diseases within a single subject will be a critical step toward translating and integrating artificial intelligence systems into the heterogeneous real-world clinical workflow.
Read Full Article (External Site)
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated his career to pushing the boundaries of human capabilities and understanding.
Armed with a Master of Science degree and a Ph.D. in his field, Dr. Lowemann has consistently been at the forefront of research and innovation, delving into ways to optimize human performance, cognition, and overall well-being. His work at the Institute revolves around a profound commitment to harnessing cutting-edge science and technology to help individuals lead more fulfilling and intelligent lives.
Dr. Lowemann’s influence extends to the educational platform BetterSmarter.me, where he shares his insights, findings, and personal development strategies with a broader audience. His ongoing mission is shaping the way we perceive and leverage the vast capacities of the human mind, offering invaluable contributions to society’s overall success and collective well-being.